Contact
Please use this form to send email to PR contact of this press release:
Onxeo Grants Exclusive Worldwide License of Validive® Developed for the Treatment of Oral Severe Mucositis to Monopar Therapeutics
TO:
Please use this form to send email to PR contact of this press release:
Onxeo Grants Exclusive Worldwide License of Validive® Developed for the Treatment of Oral Severe Mucositis to Monopar Therapeutics
TO: